These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 25805011)

  • 1. Low eicosapentaenoic acid to arachidonic acid ratio is associated with thin-cap fibroatheroma determined by optical coherence tomography.
    Wakabayashi Y; Funayama H; Ugata Y; Taniguchi Y; Hoshino H; Ako J; Momomura S
    J Cardiol; 2015 Dec; 66(6):482-8. PubMed ID: 25805011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum n-3 to n-6 polyunsaturated fatty acids ratio correlates with coronary plaque vulnerability: an optical coherence tomography study.
    Hasegawa T; Otsuka K; Iguchi T; Matsumoto K; Ehara S; Nakata S; Nishimura S; Kataoka T; Shimada K; Yoshiyama M
    Heart Vessels; 2014 Sep; 29(5):596-602. PubMed ID: 24005765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated levels of systemic pentraxin 3 are associated with thin-cap fibroatheroma in coronary culprit lesions: assessment by optical coherence tomography and intravascular ultrasound.
    Koga S; Ikeda S; Yoshida T; Nakata T; Takeno M; Masuda N; Koide Y; Kawano H; Maemura K
    JACC Cardiovasc Interv; 2013 Sep; 6(9):945-54. PubMed ID: 23954061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eicosapentaenoic acid to arachidonic acid (EPA/AA) ratio as an associated factor of high risk plaque on coronary computed tomography in patients without coronary artery disease.
    Nagahara Y; Motoyama S; Sarai M; Ito H; Kawai H; Takakuwa Y; Miyagi M; Shibata D; Takahashi H; Naruse H; Ishii J; Ozaki Y
    Atherosclerosis; 2016 Jul; 250():30-7. PubMed ID: 27175609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stabilizing effect of combined eicosapentaenoic acid and statin therapy on coronary thin-cap fibroatheroma.
    Nishio R; Shinke T; Otake H; Nakagawa M; Nagoshi R; Inoue T; Kozuki A; Hariki H; Osue T; Taniguchi Y; Iwasaki M; Hiranuma N; Konishi A; Kinutani H; Shite J; Hirata K
    Atherosclerosis; 2014 May; 234(1):114-9. PubMed ID: 24637411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of eicosapentaenoic acid treatment on the fibrous cap thickness in patients with coronary atherosclerotic plaque: an optical coherence tomography study.
    Yamano T; Kubo T; Shiono Y; Shimamura K; Orii M; Tanimoto T; Matsuo Y; Ino Y; Kitabata H; Yamaguchi T; Hirata K; Tanaka A; Imanishi T; Akasaka T
    J Atheroscler Thromb; 2015; 22(1):52-61. PubMed ID: 25132379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct morphological features of ruptured culprit plaque for acute coronary events compared to those with silent rupture and thin-cap fibroatheroma: a combined optical coherence tomography and intravascular ultrasound study.
    Tian J; Ren X; Vergallo R; Xing L; Yu H; Jia H; Soeda T; McNulty I; Hu S; Lee H; Yu B; Jang IK
    J Am Coll Cardiol; 2014 Jun; 63(21):2209-16. PubMed ID: 24632266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accuracy of computed tomography angiography to identify thin-cap fibroatheroma detected by optical coherence tomography.
    Tomizawa N; Yamamoto K; Inoh S; Nojo T; Nakamura S
    J Cardiovasc Comput Tomogr; 2017; 11(2):129-134. PubMed ID: 28214139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma Pentraxin3 Level Is Associated With Plaque Vulnerability Assessed by Optical Coherence Tomography in Patients With Coronary Artery Disease.
    Tazaki R; Tanigawa J; Fujisaka T; Shibata K; Takeda Y; Ishihara T; Hoshiga M; Hanafusa T; Ishizaka N
    Int Heart J; 2016; 57(1):18-24. PubMed ID: 26673442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plaque characteristics of thin-cap fibroatheroma evaluated by OCT and IVUS.
    Miyamoto Y; Okura H; Kume T; Kawamoto T; Neishi Y; Hayashida A; Yamada R; Imai K; Saito K; Yoshida K
    JACC Cardiovasc Imaging; 2011 Jun; 4(6):638-46. PubMed ID: 21679899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of cholesterol metabolism on coronary plaque vulnerability of target vessels: a combined analysis of virtual histology intravascular ultrasound and optical coherence tomography.
    Nasu K; Terashima M; Habara M; Ko E; Ito T; Yokota D; Ishizuka S; Kurita T; Kimura M; Kinoshita Y; Asakura Y; Tsuchikane E; Katoh O; Suzuki T
    JACC Cardiovasc Interv; 2013 Jul; 6(7):746-55. PubMed ID: 23769651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of coronary plaque morphology assessed by optical coherence tomography on cardiac troponin elevation in patients with non-ST segment elevation acute coronary syndrome.
    Lee T; Murai T; Isobe M; Kakuta T
    Catheter Cardiovasc Interv; 2017 Nov; 90(6):905-914. PubMed ID: 28303685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atherosclerotic plaque characterization by CT angiography for identification of high-risk coronary artery lesions: a comparison to optical coherence tomography.
    Nakazato R; Otake H; Konishi A; Iwasaki M; Koo BK; Fukuya H; Shinke T; Hirata K; Leipsic J; Berman DS; Min JK
    Eur Heart J Cardiovasc Imaging; 2015 Apr; 16(4):373-9. PubMed ID: 25246503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between coronary plaque vulnerability and serum n-3/n-6 polyunsaturated fatty acid ratio.
    Kashiyama T; Ueda Y; Nemoto T; Wada M; Masumura Y; Matsuo K; Nishio M; Hirata A; Asai M; Kashiwase K; Kodama K
    Circ J; 2011; 75(10):2432-8. PubMed ID: 21778590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating malondialdehyde-modified low-density lipoprotein levels are associated with the presence of thin-cap fibroatheromas determined by optical coherence tomography in coronary artery disease.
    Matsuo Y; Kubo T; Okumoto Y; Ishibashi K; Komukai K; Tanimoto T; Ino Y; Kitabata H; Hirata K; Imanishi T; Akagi H; Akasaka T
    Eur Heart J Cardiovasc Imaging; 2013 Jan; 14(1):43-50. PubMed ID: 22573905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Platelet to lymphocyte ratio with non-culprit atherosclerotic plaque vulnerability in patients with acute coronary syndrome: an optical coherence tomography study.
    Wang X; Xie Z; Liu X; Huang X; Lin J; Huang D; Yu B; Hou J
    BMC Cardiovasc Disord; 2017 Jul; 17(1):175. PubMed ID: 28673240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of the eicosapentaenoic acid to arachidonic acid ratio on plaque characteristics in statin-treated patients with coronary artery disease.
    Asakura K; Minami Y; Nagata T; Katamine M; Katsura A; Hashimoto T; Kinoshita D; Ako J
    J Clin Lipidol; 2023; 17(1):189-196. PubMed ID: 36517412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory markers and plaque morphology: an optical coherence tomography study.
    Bouki KP; Katsafados MG; Chatzopoulos DN; Psychari SN; Toutouzas KP; Charalampopoulos AF; Sakkali EN; Koudouri AA; Liakos GK; Apostolou TS
    Int J Cardiol; 2012 Feb; 154(3):287-92. PubMed ID: 20974497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of thin-cap fibroatheroma on predicting deteriorated coronary flow during interventional procedures in acute as well as stable coronary syndromes: insights from optical coherence tomography analysis.
    Gamou T; Sakata K; Matsubara T; Yasuda T; Miwa K; Inoue M; Kanaya H; Konno T; Hayashi K; Kawashiri M; Yamagishi M
    Heart Vessels; 2015 Nov; 30(6):719-27. PubMed ID: 25037112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. iMap-Intravascular Ultrasound Radiofrequency Signal Analysis Reflects Plaque Components of Optical Coherence Tomography-Derived Thin-Cap Fibroatheroma.
    Koga S; Ikeda S; Miura M; Yoshida T; Nakata T; Koide Y; Kawano H; Maemura K
    Circ J; 2015; 79(10):2231-7. PubMed ID: 26289833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.